Non-antibiotic treatment for bacterial infections: How to validate chance findings

Clinical Microbiology and Infection

Volumn 15, Issue 4, 2009, Pages 298-301

  Leibovici, L ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

ACE inhibitors; Observational studies; Pneumonia; Review; Sepsis; Statins

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; BACTERIAL INFECTION; DISEASE SEVERITY; DRUG INDICATION; HEALTH CARE ACCESS; HUMAN; METHODOLOGY; OBSERVATIONAL STUDY; PATIENT PARTICIPATION; PNEUMONIA; PRIORITY JOURNAL; PUBLISHING; SEPSIS; VALIDATION PROCESS;

BACTERIA (MICROORGANISMS);

EID: 65449167608     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02754.x     Document Type: Article

References (30)

1. Fraser A, Paul M, Almanasreh N et al. Benefit of appropriate empirical antibiotic treatment: Thirty-day mortality and duration of hospital stay. Am J Med 2006; 119: 970-976.
2. Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003; 115: 529-535.
3. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118: 146-155.
4. Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998; 244: 379-386.
5. Cohen J. Non-antibiotic strategies for sepsis. Clin Microbiol Infect 2009; 15: 302-307.
6. Amit M, Pitlik SD, Samra Z, Kenigsberger H, Drucker M, Leibovici L. Bacteremia in patients without known underlying disorders. Scand J Infect Dis 1994; 26: 605-609.
7. Thomsen RW, Riis A, Kornum JB, Christensen S, Johnsen SP, Sørensen HT. Preadmission use of statins and outcomes after hospitalization with pneumonia: Population-based cohort study of 29,900 patients. Arch Intern Med 2008; 168: 2067-2068.
8. Chalmers JD, Singanayagam A, Murray MP, Hill AT. Prior statin use is associated with improved outcomes in community-acquired pneumonia. Am J Med 2008; 121: 1002-1007.
9. Falagas ME, Makris GC, Matthaiou DK, Rafailidis PI. Statins for infection and sepsis: A systematic review of the clinical evidence. J Antimicrob Chemother 2008; 61: 774-785.
10. Rafailidis PI, Matthaiou DK, Varbobitis I, Falagas ME. Use of ACE inhibitors and risk of community-acquired pneumonia: A review. Eur J Clin Pharmacol 2008; 64: 565-573.
11. Mortensen EM, Restrepo MI, Copeland LA et al. Impact of previous statin and angiotensin II receptor blocker use on mortality in patients hospitalized with sepsis. Pharmacotherapy 2007; 27: 1619-1626.
12. Hennen R, Friedrich I, Hoyer D et al. Autonomic dysfunction and beta-adrenergic blockers in multiple organ dysfunction syndrome. Dtsch Med Wochenschr 2008; 133: 2500-2504.
13. Bratzler DW, Ma A, Nsa W. Initial antibiotic selection and patient outcomes: Observations from the National Pneumonia Project. Clin Infect Dis 2008; 47 (suppl 3): S193-S201.
14. Restrepo MI, Mortensen EM, Waterer GW, Wunderink RG, Coalson JJ, Anzueto A. Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia. Eur Respir J 2009; 33: 153-159.
15. Leibovici L. Effects of remote, retroactive intercessory prayer on outcomes in patients with bloodstream infection: A randomised controlled trial. BMJ 2001; 323: 1450-1451.
16. Leibovici L. Effect of retroactive intercessory prayer: Author's reply. BMJ 2002; 324: 1037.
17. Leibovici L. Alternative (complementary) medicine: A cuckoo in the nest of empiricist reed warblers. BMJ 1999; 319: 1629-1631.
18. Winkler F, Angele B, Pfister HW, Koedel U. Simvastatin attenuates leukocyte recruitment in experimental bacterial meningitis. Int Immunopharmacol 2009; 9: 371-374.
19. Chaudhry MZ, Wang JH, Blankson S, Redmond HP. Statin (cerivastatin) protects mice against sepsis-related death via reduced proinflammatory cytokines and enhanced bacterial clearance. Surg Infect (Larchmt) 2008; 9: 183-194.
20. Jerwood S, Cohen J. Unexpected antimicrobial effect of statins. J Antimicrob Chemother 2008; 61: 362-364.
21. Wiel E, Pu Q, Leclerc J et al. Effects of the angiotensin-converting enzyme inhibitor perindopril on endothelial injury and hemostasis in rabbit endotoxic shock. Intensive Care Med 2004; 30: 1652-1659.
22. Tribouilloy C, Rusinaru D, Leborgne L, Peltier M, Massy Z, Slama M. Prognostic impact of angiotensin-converting enzyme inhibitor therapy in diastolic heart failure. Am J Cardiol 2008; 101: 639-644.
23. Ahmed A, Centor RM, Weaver MT, Perry GJ. A propensity score analysis of the impact of angiotensin-converting enzyme inhibitors on long-term survival of older adults with heart failure and perceived contraindications. Am Heart J 2005; 149: 737-743.
24. Weitzen S, Lapane KL, Toledano AY, Hume AL, Mor V. Principles for modeling propensity scores in medical research: A systematic literature review. Pharmacoepidemiol Drug Saf 2004; 13: 841-853.
25. Austin PC. A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Stat Med 2008; 27: 2037-2049.
26. Ottenbacher KJ, Ottenbacher HR, Tooth L, Ostir GV. A review of two journals found that articles using multivariable logistic regression frequently did not report commonly recommended assumptions. J Clin Epidemiol 2004; 57: 1147-1152.
27. Ostir GV, Uchida T. Logistic regression: A nontechnical review. Am J Phys Med Rehabil 2000; 79: 565-572.
28. Hosmer DW, Hosmer T, Le Cessie S, Lemeshow S. A comparison of goodness-of-fit tests for the logistic regression model. Stat Med 1997; 16: 965-980.
29. Majumdar SR, McAlister FA, Eurich DT, Padwal RS, Marrie TJ. Statins and outcomes in patients admitted to hospital with community acquired pneumonia: Population based prospective cohort study. BMJ 2006; 333: 999-1001.
30. Kanda A, Ebihara S, Yasuda H, Takashi O, Sasaki T, Sasaki H. A combinatorial therapy for pneumonia in elderly people. J Am Geriatr Soc 2004; 52: 846-847.